Publications by authors named "Julie Curtsinger"

Claim this Profile
C
CMV Triplex Vaccine to Enhance Adaptive NK and T-cell Reconstitution After Autologous Hematopoietic Cell Transplantation.
Armin Rashidi, Corinna La Rosa, Julie Curtsinger, Qing Cao, Qiao Zhou

Transplant Cell Ther· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-in-human trial of rhIL-15 and haploidentical natural killer cell therapy for advanced acute myeloid leukemia.
Sarah Cooley, Fiona He, Veronika Bachanova, Gregory M Vercellotti, Todd E DeFor, Julie M Curtsinger

Blood Adv· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monocyte Subpopulation Recovery as Predictors of Hematopoietic Cell Transplantation Outcomes.
Lucie M Turcotte, Qing Cao, Sarah A Cooley, Julie Curtsinger, Shernan G Holtan

Biol Blood Marrow Transplant· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recipient single nucleotide polymorphisms in Paneth cell antimicrobial peptide genes and acute graft-versus-host disease: analysis of BMT CTN-0201 and -0901 samples.
Armin Rashidi, Ryan Shanley, Sophia L Yohe, Bharat Thyagarajan, Julie Curtsinger

Br J Haematol· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between recipient TNF rs361525 and acute GVHD: results from analysis of BMT CTN-0201 samples.
Armin Rashidi, Ryan Shanley, Sophia L Yohe, Bharat Thyagarajan, Julie Curtsinger

Bone Marrow Transplant· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase 1 Trial of CNDO-109-Activated Natural Killer Cells in Patients with High-Risk Acute Myeloid Leukemia.
Todd A Fehniger, Jeffrey S Miller, Robert K Stuart, Sarah Cooley, Amandeep Salhotra, Julie Curtsinger

Biol Blood Marrow Transplant· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adaptive NK Cells Resist Regulatory T-cell Suppression Driven by IL37.
Dhifaf Sarhan, Keli L Hippen, Amanda Lemire, Skyler Hying, Xianghua Luo, Julie Curtsinger

Cancer Immunol Res· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Reconstitution of NK and γδ T Cells and Its Implication for the Design of Post-Transplant Immunotherapy.
Moniek A de Witte, Dhifaf Sarhan, Zachary Davis, Martin Felices, Daniel A Vallera, Julie Curtsinger

Biol Blood Marrow Transplant· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical-scale production of cGMP compliant CD3/CD19 cell-depleted NK cells in the evolution of NK cell immunotherapy at a single institution.
Shelly M Williams, Darin Sumstad, Diane Kadidlo, Julie Curtsinger, Xianghua Luo

Transfusion· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
161533 TriKE stimulates NK-cell function to overcome myeloid-derived suppressor cells in MDS.
Dhifaf Sarhan, Ludwig Brandt, Martin Felices, Karolin Guldevall, Todd Lenvik, Julie Curtsinger

Blood Adv· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Absence of early HHV-6 reactivation after cord blood allograft predicts powerful graft-versus-tumor effect.
Armin Rashidi, Maryam Ebadi, Bassil Said, Qing Cao, Ryan Shanley, Julie Curtsinger

Am J Hematol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delayed immune reconstitution after allogeneic transplantation increases the risks of mortality and chronic GVHD.
Nelli Bejanyan, Claudio G Brunstein, Qing Cao, Aleksandr Lazaryan, Xianghua Luo, Julie Curtsinger

Blood Adv· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Haploidentical natural killer cells induce remissions in non-Hodgkin lymphoma patients with low levels of immune-suppressor cells.
Veronika Bachanova, Dhifaf Sarhan, Todd E DeFor, Sarah Cooley, Angela Panoskaltsis-Mortari, Julie M Curtsinger

Cancer Immunol Immunother· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dendritic Cell Recovery Impacts Outcomes after Umbilical Cord Blood and Sibling Donor Transplantation for Hematologic Malignancies.
Waseem Touma, Claudio G Brunstein, Qing Cao, Jeffrey S Miller, Julie Curtsinger

Biol Blood Marrow Transplant· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization of cGMP purification and expansion of umbilical cord blood-derived T-regulatory cells in support of first-in-human clinical trials.
David H McKenna, Darin Sumstad, Diane M Kadidlo, Bjorn Batdorf, Colin J Lord, Julie M Curtsinger

Cytotherapy· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fewer Circulating Natural Killer Cells 28 Days After Double Cord Blood Transplantation Predicts Inferior Survival and IL-15 Response.
Rachel J Bergerson, Robin Williams, Hongbo Wang, Ryan Shanley, Gretchen Colbenson, Julie Curtsinger

Blood Adv· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Umbilical cord blood-derived T regulatory cells to prevent GVHD: kinetics, toxicity profile, and clinical effect.
Claudio G Brunstein, Jeffrey S Miller, David H McKenna, Keli L Hippen, Todd E DeFor, Julie Curtsinger

Blood· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Postthaw characterization of umbilical cord blood: markers of storage lesion.
Allison Hubel, Ralf Spindler, Julie M Curtsinger, Bruce Lindgren, Sara Wiederoder

Transfusion· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expansion and homing of adoptively transferred human natural killer cells in immunodeficient mice varies with product preparation and in vivo cytokine administration: implications for clinical therapy.
Jeffrey S Miller, Cliona M Rooney, Julie Curtsinger, Ron McElmurry, Valarie McCullar

Biol Blood Marrow Transplant· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clearance of acute myeloid leukemia by haploidentical natural killer cells is improved using IL-2 diphtheria toxin fusion protein.
Veronika Bachanova, Sarah Cooley, Todd E Defor, Michael R Verneris, Bin Zhang, Julie Curtsinger

Blood· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional NK cell repertoires are maintained through IL-2Rα and Fas ligand.
Martin Felices, Todd R Lenvik, Dave E M Ankarlo, Bree Foley, Julie Curtsinger

J Immunol· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevention of graft-versus-host disease by adoptive T regulatory therapy is associated with active repression of peripheral blood Toll-like receptor 5 mRNA expression.
Birgit Sawitzki, Claudio Brunstein, Christian Meisel, Julia Schumann, Katrin Vogt, Julie M Curtsinger

Biol Blood Marrow Transplant· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytotoxic T lymphocytes and vaccine development 2013.
Zhengguo Xiao, Kim Klonowski, Hanchun Yang, Julie Curtsinger

Biomed Res Int· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adoptive transfer of umbilical cord blood-derived regulatory T cells and early viral reactivation.
Claudio G Brunstein, Bruce R Blazar, Jeffrey S Miller, Qing Cao, Keli L Hippen, Julie Curtsinger

Biol Blood Marrow Transplant· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The autoimmunity-associated gene PTPN22 potentiates toll-like receptor-driven, type 1 interferon-dependent immunity.
Yaya Wang, Iftach Shaked, Stephanie M Stanford, Wenbo Zhou, Julie M Curtsinger

Immunity· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis